ArticleClinical rheumatology2023

Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection.

Suling Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.